Brilinta Alternatives Compared
| Brilinta (ticagrelor) | Semaglutide | Evolocumab |
|
|---|
| Brilinta (ticagrelor) | Semaglutide | Evolocumab |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Brilinta blocks a substance called ADP (adenosine-5-diphosphate) which plays a crucial role in blood clotting and may be given together with aspirin to people who have had a heart attack or with... View more |
Prescription only
Semaglutide lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the liver. It is taken... View more |
Prescription only
Prescribed for High Cholesterol - Familial Heterozygous, Cardiovascular Risk Reduction, High Cholesterol - Familial Homozygous, High Cholesterol. Evolocumab may also be used for purposes not listed... View more |
Related suggestions |
|||||||
| More about Brilinta (ticagrelor) | More about Semaglutide | More about Evolocumab | ||||||||
| Ratings & Reviews | ||||||||||
|
Brilinta has an average rating of 3.7 out of 10 from a total of 101 ratings on Drugs.com. 16% of reviewers reported a positive effect, while 59% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2430 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 21% reported a negative effect. |
Evolocumab has an average rating of 5.4 out of 10 from a total of 676 ratings on Drugs.com. 41% of reviewers reported a positive effect, while 44% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
View all Brilinta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
Ozempic, Rybelsus, Wegovy | Repatha | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
12.8 hours |
168 hours |
408 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 508 drugs are known to interact with Brilinta:
|
A total of 272 drugs are known to interact with Semaglutide:
|
A total of 2 drugs are known to interact with Evolocumab:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
| Disease Interactions | ||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||
| First Approval Date | ||||||||||
|
July 20, 2011 |
December 05, 2017 |
N/A |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.